Related Experiment Video
Updated: May 18, 2026

08:17
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
Image-guided ablative therapies for lung cancer
Amita Sharma1, Fereidoun Abtin, Jo-Anne O Shepard
1Department of Radiology, Massachusetts General Hospital, Founders 202, 55 Fruit Street, Boston, MA 02114, USA.
Radiologic Clinics of North America
|September 15, 2012
Summary
Image-guided ablation offers a safe alternative for lung cancer treatment in patients unsuitable for surgery. This review covers radiofrequency ablation, microwave ablation, and cryotherapy for localized lung disease.
Area of Science:
- Oncology
- Interventional Radiology
- Pulmonology
Background:
- Lung cancer is a leading cause of adult mortality.
- Surgical resection (lobectomy) is the primary treatment, but many patients are ineligible due to comorbidities, recurrence, or refusal of surgery.
- Image-guided ablation presents a viable alternative for localized lung disease in select patients.
Purpose of the Study:
- To review the principles, techniques, and follow-up of image-guided ablative therapies for lung cancer.
- To provide an overview of current ablative options for localized lung disease.
Main Methods:
- Discussion of radiofrequency ablation (RFA) principles and application.
- Review of microwave ablation (MWA) techniques and outcomes.
- Explanation of percutaneous cryotherapy procedures and management.
Main Results:
- Image-guided ablation is a safe and effective treatment modality for carefully selected patients with localized lung cancer.
- RFA, MWA, and cryotherapy are the primary ablative therapies currently employed.
- These techniques offer minimally invasive options for patients who are not candidates for traditional surgery.
Conclusions:
- Image-guided ablation provides a crucial treatment alternative for lung cancer patients unable to undergo surgery.
- Understanding the principles and techniques of RFA, MWA, and cryotherapy is essential for their successful application.
- Further research and patient selection are key to optimizing outcomes with ablative therapies.

